Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 57
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
3.
Lymphology ; 45(3): 124-9, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23342932

RESUMEN

The pathophysiology of skin diseases associated with monoclonal gammopathies is generally unknown. Our aim was to investigate whether a monoclonal gammopathy could be a causal factor in progressive lymphedema. We describe a 75 year old patient with a rapidly progressive lipo-lymphedema and a monoclonal gammopathy of unknown significance (MGUS) suspected as a key etiological factor. Dermal fibroblasts were cultured from lesional lower leg skin and non-lesional abdominal skin and compared to healthy control fibroblasts. We found 10-fold elevated basic fibroblast growth factor 2 (FGF-2) in the patient's serum and significantly increased basal FGF-2 production of lesional and non-lesional fibroblasts compared to healthy controls. Upon restimulation with patient or healthy control serum, lesional fibroblasts showed significantly increased proliferation rates and FGF-2 production in vitro. Non-lesional abdominal fibroblasts showed an intermediate phenotype between lesional and control fibroblasts. Our findings provide the first evidence that lesional dermal fibroblasts from lipo-lymphedema with plasma cell infiltration show increased proliferation and FGF-2 production and that both local tissue factors and altered FGF-2 serum levels associated with monoclonal gammopathies might contribute to this phenotype. Thus we propose a possible pathophysiologic link between the gammopathy-associated factors and the generation of lymphedema with initial fibrogenesis aggravating pre-existing lipedema.


Asunto(s)
Linfedema/etiología , Gammopatía Monoclonal de Relevancia Indeterminada/complicaciones , Anciano , Proliferación Celular , Células Cultivadas , Femenino , Factor 2 de Crecimiento de Fibroblastos/biosíntesis , Factor 2 de Crecimiento de Fibroblastos/sangre , Fibroblastos/metabolismo , Humanos , Piel/citología , Piel/metabolismo
4.
Clin Exp Dermatol ; 36(3): 270-2, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20659118

RESUMEN

We present the case of a 79-year-old patient with extensive metastatic malignant melanoma (MM) of the scalp. Cutaneous MM of the head and neck often presents a therapeutic challenge. Radical surgical procedures and conventional chemotherapy are often unfeasible and contraindicated because of the difficult anatomy, the extent of the tumour process, and systemic toxicity. In our patient, selective intra-arterial perfusion with pegylated liposomal doxorubicin (PLD) and melphalan was performed after catheterization of both bilateral external carotid arteries with an arterial port system. PLD 4.5 mg/m(2) and melphalan (1.35 mg/m(2), followed by 2.7 mg/m(2) after reaching tolerance) were given as short-term infusions at two-weekly intervals into the right and left external carotid arteries, respectively. After eight applications with tolerable side-effects, no MM cells were detected; however, infiltrates of lymphocytes and melanophages were seen. This case suggests that intra-arterial chemotherapy may be a useful treatment for metastatic melanoma of the scalp.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias de Cabeza y Cuello/secundario , Melanoma/secundario , Cuero Cabelludo , Neoplasias Cutáneas/tratamiento farmacológico , Anciano , Arteria Carótida Externa , Quimioterapia del Cáncer por Perfusión Regional/métodos , Doxorrubicina/administración & dosificación , Doxorrubicina/análogos & derivados , Femenino , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Neoplasias de Cabeza y Cuello/patología , Humanos , Melanoma/tratamiento farmacológico , Melanoma/patología , Melfalán/administración & dosificación , Polietilenglicoles/administración & dosificación , Neoplasias Cutáneas/patología
5.
Adv Tech Stand Neurosurg ; 36: 79-135, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21197609

RESUMEN

Neurosurgeons are mainly concerned with child abuse in cases of severe cranio-cerebral trauma. Aim of the present paper is to highlight the clinical picture and symptoms in cases of child abuse and our multidisciplinary approach to reveal a solid diagnosis. The detection of child abuse requires a high index of suspicion, especially in cases of subtle injuries. Besides reporting to the appropriate agencies primary goals are to terminate suspected abuse and to prevent further harm to the child. All this requires a confirmed diagnosis.


Asunto(s)
Maltrato a los Niños/diagnóstico , Maltrato a los Niños/legislación & jurisprudencia , Traumatismos Craneocerebrales , Medicina Legal , Neurocirugia , Niño , Maltrato a los Niños/estadística & datos numéricos , Traumatismos Craneocerebrales/diagnóstico , Traumatismos Craneocerebrales/epidemiología , Traumatismos Craneocerebrales/cirugía , Alemania , Humanos , Notificación Obligatoria
7.
Nervenarzt ; 82(9): 1145-50, 2011 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-21221518

RESUMEN

Already the Hippocratic Oath defines maintaining boundaries in the physician-patient relationship as an essential part of medical care: "…In every house where I come I will enter only for the good of my patients, keeping myself far from all intentional ill-doing and all seduction and especially from the pleasures of love with women or men, be they free or slaves…". The World Psychiatric Association's Declaration of Madrid 1996 specifically comments on boundary issues of physician-patient relationships in psychiatry. Boundary violations in any kind of therapeutic relationship - not only regarding psychotherapy - are both relevant and tabooed. There are hardly any options for patients concerned to find appropriate therapeutic and legal support. A public positioning of the medical profession seems to be very important. Apart from raising awareness, further important goals are prevention, guidelines for appropriate handling of victims and offenders, as well as integration of the issue in education and public discourse.


Asunto(s)
Actitud del Personal de Salud , Relaciones Médico-Paciente/ética , Mala Conducta Profesional/ética , Psiquiatría/ética , Psicoterapia/ética , Adaptación Psicológica , Ética Médica , Femenino , Humanos , Masculino , Guías de Práctica Clínica como Asunto , Delitos Sexuales/ética , Trastornos por Estrés Postraumático/diagnóstico , Trastornos por Estrés Postraumático/psicología , Suicidio/psicología , Suiza , Estados Unidos , Prevención del Suicidio
10.
Dermatology ; 217(3): 215-8, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18607109

RESUMEN

Acrodermatitis chronica atrophicans (ACA) represents the persistent late stage of borreliosis in which Borrelia species may survive for decades. Occasionally, B-cell lymphoma may develop in these patients, and additional neoplastic complications such as basal cell carcinoma or squamous cell carcinoma (SCC) have been reported once each over the past 60 years. Here we describe, to the best of our knowledge, the first case of metastatic SCC in a European patient with long-standing ACA caused by Borrelia burgdorferi sensu stricto. Our case highlights a potential pathophysiological connection of untreated Borrelia infection with the initiation or progression of SCC and should alert dermatologists to this rare complication.


Asunto(s)
Acrodermatitis/complicaciones , Borrelia burgdorferi , Carcinoma de Células Escamosas/etiología , Enfermedad de Lyme/complicaciones , Neoplasias Cutáneas/etiología , Anciano de 80 o más Años , Tobillo , Carcinoma de Células Escamosas/patología , Enfermedad Crónica , Femenino , Humanos , Enfermedad de Lyme/patología , Metástasis de la Neoplasia , Neoplasias Cutáneas/patología
11.
Hautarzt ; 59(11): 942-5, 2008 Nov.
Artículo en Alemán | MEDLINE | ID: mdl-18712322

RESUMEN

In 10%-55% of patients, leukemia cutis (LC) manifest as a symptom of acute myelomonocytic leukemia and is associated with a poor overall prognosis. Disseminated bluish-violet or red-brownish papules and plaques, nodules and also hemorrhagic ulcers may dominate the initial clinical picture. Importantly, nonspecific infiltrates (leukemids) must be differentiated from specific infiltrates of malignant cells in patients presenting with dermatoses and concomitant underlying hematopoietic neoplasms. The role of the dermatologist is the rapid clinical and dermatohistopathological diagnosis in order to allow immediate, adequate treatment of the patient's underlying systemic disease.


Asunto(s)
Dermatosis de la Pierna/patología , Leucemia Mielomonocítica Aguda/patología , Extremidad Inferior/patología , Anciano , Humanos , Masculino
12.
FEBS Lett ; 397(2-3): 343-6, 1996 Nov 18.
Artículo en Inglés | MEDLINE | ID: mdl-8955376

RESUMEN

We have studied the mechanism of action of the Serratia nuclease using deoxythymidine 3',5'-bis-(p-nitrophenyl-phosphate) as a substrate. A comparison of the activity with which the wild-type enzyme and several mutant enzymes attack this artificial substrate and herring sperm DNA, respectively, supports the suggestion that His89 is the general base and a Mg2+ ion bound to Glu127 the general acid in the mechanism of phosphodiester bond hydrolysis by the Serratia nuclease, and that Asn119 directly participates in catalysis, for example by transition state stabilisation. Arg57, Arg87 and Arg131, essential for nuclease activity, are not needed for cleavage of the artificial substrate, suggesting that they are involved in binding and positioning of nucleic acid substrates.


Asunto(s)
ADN/metabolismo , Endodesoxirribonucleasas/metabolismo , Endorribonucleasas/metabolismo , Serratia marcescens/enzimología , Nucleótidos de Timina/metabolismo , Ácido Edético/farmacología , Endodesoxirribonucleasas/genética , Endorribonucleasas/genética , Hidrólisis , Cinética , Magnesio/farmacología , Mutación , Nitrofenoles/metabolismo
13.
FEBS Lett ; 443(2): 209-14, 1999 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-9989607

RESUMEN

We show here that two nucleases, Serratia nuclease and I-PpoI, with contrasting specificities, i.e. non-specific vs. highly sequence specific, share a structurally similar active site region with conservation of the catalytically relevant histidine and asparagine residues. On the basis of a comparison of the available structures and biochemical data for wild type and mutant variants of Serratia nuclease and I-PpoI we propose that both enzymes have a common catalytic mechanism, a proposition that is supported by our finding that both enzymes accept deoxythymidine 3',5'-bis-(p-nitrophenyl phosphate) as a substrate and cleave it in an identical manner. According to this mechanism a histidine residue functions as a general base and Mg2+ bound to an asparagine residue as a Lewis acid in phosphodiester bond cleavage.


Asunto(s)
Endodesoxirribonucleasas/metabolismo , Endorribonucleasas/metabolismo , Timidina/análogos & derivados , Secuencia de Aminoácidos , ADN/metabolismo , Endodesoxirribonucleasas/química , Endorribonucleasas/química , Ésteres/metabolismo , Concentración de Iones de Hidrógeno , Hidrólisis , Intrones , Modelos Moleculares , Datos de Secuencia Molecular , Conformación Proteica , ARN/metabolismo , Homología de Secuencia de Aminoácido , Especificidad por Sustrato , Timidina/metabolismo
14.
FEBS Lett ; 425(3): 517-22, 1998 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-9563525

RESUMEN

The Serratia nuclease is a non-specific endonuclease which cleaves single- and double-stranded RNA and DNA. It is a member of a large family of related endonucleases, most of which are dimers of identical subunits, with the notable exception of the Anabaena nuclease which is a monomer. In order to find out whether the dimer state of the Serratia nuclease is essential for its function we have produced variants of this nuclease which based on the crystal structure (Miller, M.D. and Krause, K.L. (1996), Protein Science 5, 24-33) were expected to be unable to dimerise. We demonstrate here that these variants, H184A, H184N, H184T and H184R, are monomers and have the same secondary structure, stability towards chemical denaturation and activity as the wild-type enzyme. This allows to conclude that the dimeric state is not essential for the catalytic function of the Serratia nuclease. In contrast, the S179C variant which is also a monomer shows little activity, presumably because this amino acid substitution changes the structure of the enzyme.


Asunto(s)
Endonucleasas/química , Serratia/enzimología , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Catálisis , Dicroismo Circular , ADN/metabolismo , Dimerización , Endonucleasas/genética , Estabilidad de Enzimas , Ingeniería Genética , Guanidina/farmacología , Enlace de Hidrógeno , Cinética , Peso Molecular , Mutagénesis/genética , Conformación Proteica , Desnaturalización Proteica , Pliegue de Proteína , Estructura Secundaria de Proteína , ARN/metabolismo
15.
Biochem Pharmacol ; 34(22): 3983-6, 1985 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-2998394

RESUMEN

The title compound, designed as a model for the affinity moiety of a cannabinoid affinity gel was synthesized in tritiated form (sp. act. 7.27 mCi/mmole). To validate the affinity approach to isolate the putative THC receptor, the properties of the amide were studied. Upon i.p. injection in mice the amide reaches peak brain levels of 0.13% of the total dose after 15 min. Following i.v. injection, maximal brain concentrations of 1.9% are observed at 5 min. Compared to delta 9-THC, which distributes almost equally between triglyceride and phospholipid phases (51:49) the amide exhibits a strong preference for phospholipids (5:95) that can be interpreted as high relative membrane affinity. In rats trained in a water maze to discriminate between i.p. injections of 3 mg/kg delta 9-THC (ED50 = 1.8 mg/kg) and its vehicle, the amide was generalized to the training drug, being five times less potent (ED50 = 8.7 mg/kg) than delta 9-THC. This demonstration of cannabis-like activity indicates that the amide retains affinity to the postulated receptor and justifies the choice for the affinity ligand.


Asunto(s)
Encéfalo/metabolismo , Aprendizaje Discriminativo/efectos de los fármacos , Dronabinol/análogos & derivados , Dronabinol/farmacología , Generalización del Estimulo/efectos de los fármacos , Animales , Dronabinol/metabolismo , Cinética , Ligandos , Masculino , Ratones , Fosfolípidos , Ratas , Solubilidad , Triglicéridos
16.
J Cancer Res Clin Oncol ; 128(3): 161-6, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11935303

RESUMEN

BACKGROUND: Rituximab is a genetically engineered antibody recognizing the CD20 antigen known to be expressed by more than 95% of B-cell lymphomas. Recently the antibody has been approved for routine administration in primary extracutaneous, treatment-refractory or relapsed low-grade, follicular non-Hodgkin B-cell lymphomas. With regard to the pathogenetically related primary cutaneous lymphomas, the so-called large B-cell lymphoma of the leg represents a distinct, but rare subentity. In an 89-year-old, multimorbid patient who was affected by such a non-resectable CD20+ large B-cell lymphoma limited to the skin of both lower legs, rituximab was used as a first-line monotherapy in order to avoid local or systemic toxicities inevitably linked to conventional treatment modalities, i.e., radio- or chemotherapy. METHODS: Rituximab was administered at a dosage of 375 mg/m(2) i.v. eight times in weekly intervals. As a premedication we used prednisolone 150 mg i.v. as well as loratadine 10 mg p.o. 1 h before each rituximab infusion. RESULTS: The treatment was well tolerated without any adverse reactions, but was accompanied by a mild transient blood eosinophilia. The histologically proven, exophytic, multi-nodular lymphoma showed a substantial regression already at 2 weeks after the onset of the rituximab treatment. At 8 weeks we observed a complete clinical remission which is now stabile for a follow-up period of 6 months without any maintenance therapy. CONCLUSIONS: Our case observation demonstrates that an intensified, i.e. eightfold, rituximab application in weekly intervals may be a highly effective, tumor target cell-specific first-line monotherapy in the management of primary cutaneous large B-cell lymphoma of the leg. Given the rareness of the disease, the result as well as the possible contribution of the prednisolone premedication will have to be evaluated in a future, controlled, multi-centre study.


Asunto(s)
Anticuerpos Monoclonales/farmacología , Antineoplásicos/farmacología , Linfoma de Células B/tratamiento farmacológico , Linfoma de Células B/inmunología , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/inmunología , Anciano , Anciano de 80 o más Años , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales de Origen Murino , Antígenos CD20/análisis , Antineoplásicos/administración & dosificación , Esquema de Medicación , Humanos , Infusiones Intravenosas , Pierna/patología , Linfoma de Células B/patología , Masculino , Rituximab , Neoplasias Cutáneas/patología , Resultado del Tratamiento
17.
J Biotechnol ; 87(2): 131-41, 2001 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-11278037

RESUMEN

Due to their high enzymatic activity, the sugar-non-specific endonucleases from Serratia marcescens and Anabaena can be used for a number of applications, such as the removal of contaminating genetic material from biological preparations, footprinting studies, and the determination of nucleic acids in biochemical samples. These methods would benefit from immobilized nucleases. For this purpose, a single cysteine residue was added at the N-terminus of the Serratia and Anabaena nucleases and subsequently modified with a maleimide-biotin conjugate. Alternatively, a biotin acceptor domain was fused to the Anabaena nuclease, allowing biotinylation during expression in E. coli without a further chemical step. The attachment of biotin-modified nucleases to streptavidin-coated paramagnetic beads and to streptavidin-coated surface plasmon resonance sensor chips (to study interactions with substrate and inhibitor) worked well when aggregates present in the protein preparations were removed by ultrafiltration. These methods should be of general use for similar enzyme systems.


Asunto(s)
Biotina/química , Endodesoxirribonucleasas/química , Endonucleasas , Endorribonucleasas/química , Enzimas Inmovilizadas/química , Hidrolasas Diéster Fosfóricas/química , Estreptavidina/química , Secuencia de Aminoácidos , Secuencia de Bases , Biotina/metabolismo , Metabolismo de los Hidratos de Carbono , Cromatografía en Gel/métodos , Codón/genética , Cisteína/genética , Endodesoxirribonucleasas/genética , Endodesoxirribonucleasas/metabolismo , Endorribonucleasas/genética , Endorribonucleasas/metabolismo , Enzimas Inmovilizadas/metabolismo , Datos de Secuencia Molecular , Hidrolasas Diéster Fosfóricas/genética , Hidrolasas Diéster Fosfóricas/metabolismo , Ingeniería de Proteínas/métodos , Receptores de Factores de Crecimiento/genética , Estreptavidina/metabolismo , Resonancia por Plasmón de Superficie , Ultrafiltración
18.
Eur J Dermatol ; 9(6): 477-9, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10491507

RESUMEN

We report on the rare case of a 64-year-old European woman with a viral acanthoma of the oral mucosa of the clinical Heck type with unprecedented molecular-biological proof of HPV 24 DNA and so far undescribed malignant transformation with a long existence of the vegetation. After surgical therapy a circumscribed relapse of viral acanthoma developed, which responded favourably to a combined antiviral and antiproliferative therapy with acitretin perorally and interferon, first subcutaneously, later intralesionally for 3 months.


Asunto(s)
Carcinoma de Células Escamosas/patología , ADN Viral/análisis , Hiperplasia Epitelial Focal/virología , Neoplasias de la Boca/patología , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/patología , Infecciones Tumorales por Virus/patología , Biopsia con Aguja , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/terapia , Transformación Celular Neoplásica/patología , Diagnóstico Diferencial , Femenino , Hiperplasia Epitelial Focal/patología , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Neoplasias de la Boca/diagnóstico , Neoplasias de la Boca/terapia , Infecciones por Papillomavirus/diagnóstico , Infecciones Tumorales por Virus/diagnóstico
19.
Child Abuse Negl ; 38(7): 1267-74, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24636360

RESUMEN

Posterior rib fractures are highly indicative of non-accidental trauma (NAT) in infants. Since 2000, the "two-thumbs" technique for cardiopulmonary resuscitation (CPR) of newborns and infants has been recommended by the American Heart Association (AHA). This technique is similar to the grip on an infant's thorax while shaking. Is it possible that posterior rib fractures in newborns and infants could be caused by the "two-thumbs" technique? Using computerized databases from three German children's hospitals, we identified all infants less than 12 months old who underwent professional CPR within a 10-year period. We included all infants with anterior-posterior chest radiographs taken after CPR. Exclusion criteria were sternotomy, osteopenia, various other bone diseases and NAT. The radiographs were independently reviewed by the Chief of Pediatric Radiology (MB) and a Senior Pediatrician, Head of the local Child Protection Team (IF). Eighty infants with 546 chest radiographs were identified, and 50 of those infants underwent CPR immediately after birth. Data concerning the length of CPR was available for 41 infants. The mean length of CPR was 11min (range: 1-180min, median: 3min). On average, there were seven radiographs per infant. A total of 39 infants had a follow-up radiograph after at least 10 days. No rib fracture was visible on any chest X-ray. The results of this study suggest rib fracture after the use of the "two-thumbs" CPR technique is uncommon. Thus, there should be careful consideration of abuse when these fractures are identified, regardless of whether CPR was performed and what technique used. The discovery of rib fractures in an infant who has undergone CPR without underlying bone disease or major trauma warrants a full child protection investigation.


Asunto(s)
Reanimación Cardiopulmonar/estadística & datos numéricos , Maltrato a los Niños/diagnóstico , Fracturas de las Costillas/epidemiología , Reanimación Cardiopulmonar/efectos adversos , Reanimación Cardiopulmonar/métodos , Maltrato a los Niños/estadística & datos numéricos , Femenino , Alemania/epidemiología , Humanos , Lactante , Recién Nacido , Masculino , Radiografía , Fracturas de las Costillas/diagnóstico por imagen , Fracturas de las Costillas/etiología
20.
Rofo ; 185(3): 262-7, 2013 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-23154862

RESUMEN

PURPOSE: To compare the dose area products of pediatric VCUG in daily practice with the dramatically reduced official German diagnostic reference levels, which are based on selected data. MATERIALS AND METHODS: 413 consecutive pediatric VCUG examinations were analyzed. RESULTS: The mean dose area product of all examinations was 0.97 dGycm². This is below the lowest reference level that is valid for neonates. In 12 cases (5.6 %) the achieved dose area product was higher than the corresponding reference level. CONCLUSION: Using the available techniques for radiation protection, it is possible in the daily routine to meet the official diagnostic reference levels for children, which have been reduced by up to 80 %, even though these levels are based on a selected, possibly non-representative data set.


Asunto(s)
Fluoroscopía/métodos , Dosis de Radiación , Monitoreo de Radiación/legislación & jurisprudencia , Monitoreo de Radiación/métodos , Protección Radiológica/legislación & jurisprudencia , Protección Radiológica/métodos , Urodinámica/fisiología , Urografía/métodos , Reflujo Vesicoureteral/diagnóstico por imagen , Adolescente , Factores de Edad , Niño , Preescolar , Relación Dosis-Respuesta en la Radiación , Femenino , Fluoroscopía/normas , Alemania , Humanos , Lactante , Recién Nacido , Masculino , Monitoreo de Radiación/normas , Protección Radiológica/normas , Valores de Referencia , Estudios Retrospectivos , Urografía/normas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA